Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04841226 · ClinicalTrials.gov registry record · NA
Randomized Study of Silq Urinary Catheter
A NA study, sponsored by Silq Technologies Corporation.
- Completed
- Registry status
- NA
- Development phase
- 158
- Enrollment target
NCT04841226 is a NA study that has completed, run by Silq Technologies Corporation. The registered enrollment target is 158 participants.
The verdict
NCT04841226, a NA study, has completed, sponsored by Silq Technologies Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 158 participants
- Enrollment target
Study Summary
To assess the ability of the Silq ClearTract™ 100% Silicone 2-Way Foley Catheter to reduce biofilm formation in subjects that require a long-term indwelling Foley catheter when compared to other commercially available urinary catheters.
Interventions
- DEVICE Long-term indwelling Foley catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2021-12-28 |
| Est. Completion | 2024-08-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04841226
The ClinicalTrials.gov registry entry for NCT04841226 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 158 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Silq Technologies Corporation, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Long-term indwelling Foley catheter is the first listed.
NCT04841226 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04841226 about?
NCT04841226 is a clinical study titled "Randomized Study of Silq Urinary Catheter". To assess the ability of the Silq ClearTract™ 100% Silicone 2-Way Foley Catheter to reduce biofilm formation in subjects that require a long-term indwelling Foley catheter when compared to other commercially available urinary catheters.
What is the current status of trial NCT04841226?
This trial is currently completed. It is a NA study. The enrollment target is 158 participants. The study started on 2021-12-28. Estimated completion is 2024-08-15.
What interventions are being tested in trial NCT04841226?
The interventions under investigation include: Long-term indwelling Foley catheter (DEVICE).
Who is sponsoring clinical trial NCT04841226?
This trial is sponsored by Silq Technologies Corporation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.